Lv11
100 积分 2024-11-14 加入
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
1小时前
已完结
Phase 2 study of amivantamab plus lazertinib in previously-treated patients with EGFR mutant lung cancers with brain and leptomeningeal metastases
26天前
已完结
Phase 2 study of amivantamab plus lazertinib in previously-treated patients with EGFR mutant lung cancers with brain and leptomeningeal metastases
26天前
已完结
Evolution of claudin18.2 therapies in gastroesophageal cancers
2个月前
已完结
Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer A Randomized Clinical Trial
4个月前
已关闭
Surviving Burnout as an Oncologist
9个月前
已完结
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma
9个月前
已完结
Aspirin is associated with lower risk of pancreatic cancer and cancer-related mortality in patients with diabetes mellitus
9个月前
已完结
皖公网安备34019202002308
